NDC 0169-4132

Ozempic

Semaglutide

Ozempic is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Semaglutide.

• Product ID: 0169-4132_16fb5f2c-ad9e-4a1e-9a82-6c888cd7fe13
• NDC: 0169-4132
• Product Type: Human Prescription Drug
• Proprietary Name: Ozempic
• Generic Name: Semaglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2017-12-06
• Marketing Category: NDA / NDA
• Application Number: NDA209637
• Labeler Name: Novo Nordisk
• Substance Name: SEMAGLUTIDE
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0169-4132-12

1 SYRINGE, PLASTIC in 1 CARTON (0169-4132-12) > 1.5 mL in 1 SYRINGE, PLASTIC (0169-4132-11)

• Marketing Start Date: 2017-12-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0169-4132-90 [00169413290]

Ozempic INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA209637
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-12-06

NDC 0169-4132-12 [00169413212]

Ozempic INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA209637
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-12-06

NDC 0169-4132-97 [00169413297]

Ozempic INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA209637
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-12-06

NDC 0169-4132-11 [00169413211]

Ozempic INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA209637
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-12-06

Drug Details

Active Ingredients

Ingredient	Strength
SEMAGLUTIDE	1.34 mg/mL

OpenFDA Data

• SPL SET ID: adec4fd2-6858-4c99-91d4-531f5f2a2d79
• Manufacturer:
  • Novo Nordisk
• UNII:
  • 53AXN4NNHX
• RxNorm Concept Unique ID - RxCUI:
  • 1991311
  • 1991317
  • 1991316
  • 1991306

Pharmacological Class

• GLP-1 Receptor Agonist [EPC]
• Glucagon-Like Peptide 1 [CS]
• Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

NDC Crossover Matching brand name "Ozempic" or generic name "Semaglutide"

NDC	Brand Name	Generic Name
0169-4130	Ozempic	semaglutide
0169-4132	Ozempic	semaglutide
0169-4136	Ozempic	semaglutide
0169-4181	Ozempic	semaglutide
0169-4772	Ozempic	semaglutide
50090-5138	Ozempic	semaglutide
50090-5139	Ozempic	semaglutide
70518-2143	Ozempic	Ozempic
0169-4501	WEGOVY	semaglutide
0169-4505	WEGOVY	semaglutide
0169-4517	WEGOVY	semaglutide
0169-4524	WEGOVY	semaglutide
0169-4525	WEGOVY	semaglutide